Detalhe da pesquisa
1.
Diabetes Technology Meeting 2023.
J Diabetes Sci Technol
; : 19322968241235205, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528741
2.
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
J Diabetes Sci Technol
; 17(5): 1226-1242, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348391
3.
Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination.
touchREV Endocrinol
; 17(1): 12-20, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118442
4.
Recreational diving in persons with type 1 and type 2 diabetes: Advancing capabilities and recommendations.
Diving Hyperb Med
; 50(2): 135-143, 2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557415
5.
Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control.
J Diabetes Sci Technol
; 10(5): 1027-33, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226388
6.
Editorial: Physical Activity and Type 1 Diabetes.
Front Endocrinol (Lausanne)
; 10: 860, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31866952
7.
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.
Diabetes Care
; 34(3): 661-5, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21270174